M. pneumoniae | C. pneumoniae | Co-infection | |
---|---|---|---|
(n = 199) | (n = 81) | (n = 15) | |
Cell immunity | |||
CD3+ (%) | 63.6 ± 9.4 | 65.3 ± 9.3 | 61.9 ± 8.3 |
CD3 + CD4+ (%) | 36.8 ± 8.2 | 37.5 ± 8.6 | 33.9 ± 4.4 |
CD3 + CD8+ (%) | 22.9 ± 6.7 | 24.1 ± 5.7 | 23.6 ± 8.1 |
CD4/CD8 (%) | 1.8 ± 0.8 | 1.7 ± 0.7 | 1.6 ± 0.6 |
CD3-CD19+ (%) | 26.2 ± 9.8 | 26.1 ± 8.9 | 29.7 ± 9.2 |
CD3-CD (16 + 56+) (%) | 8.8 ± 5.7 | 6.6 ± 3.9 | 6.8 ± 2.8 |
CD19 + CD23+ (%) | 6.6 ± 3.6 | 6.9 ± 2.9 | 7.8 ± 2.5 |
CD4 + CD25+ (%) | 7.4 ± 3.5 | 6.0 ± 3.7 | 7.0 ± 2.4 |
Chest X-rays (LRTI) * | n = 171 | n = 66 | n = 13 |
Lobar consolidation (%) | 23 (13.5) | 7 (10.6) | 2 (15.4) |
Infiltration/opacities (%) | 105 (61.4) | 41 (62.1) | 8 (61.5) |
Hyper aeration (%) | 16 (9.4) | 10 (15.2) | 2 (15.4) |
Interstitial lesions (%) | 59 (34.5) | 25 (37.9) | 4 (30.8) |
Pleural reaction (%) | 4 (2.3) | 0 (0) | 1 (7.7) |
Tidal lung function (LRTI) | n = 82 | n = 54 | n = 9 |
Normal (0) | 13 (15.9) | 9 (16.7) | 1 (11.1) |
Mild (1–3) | 22 (26.8) | 6 (11.1) | 1 (11.1) |
Moderate (4–5) | 23 (28.0) | 18 (33.3) | 1 (11.1) |
Severe (6–7) | 20 (24.3) | 17 (31.5) | 4 (44.4) |
Extremely severe (8–9) | 4 (4.9) | 4 (7.4) | 2 (22.2) |